296 related articles for article (PubMed ID: 30176687)
1. [Placebo Nocebo Ethics in Communicating with Patients How Anaesthesiologists Should Handle the Psychosomatic Dimension of Briefing].
Friedrich DR; Reichardt JO; Rittner HL
Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 Sep; 53(9):592-604. PubMed ID: 30176687
[TBL] [Abstract][Full Text] [Related]
2. Unethical informed consent caused by overlooking poorly measured nocebo effects.
Howick J
J Med Ethics; 2021 Sep; 47(9):590-594. PubMed ID: 32063581
[TBL] [Abstract][Full Text] [Related]
3. When Respecting Autonomy Is Harmful: A Clinically Useful Approach to the Nocebo Effect.
Fortunato JT; Wasserman JA; Menkes DL
Am J Bioeth; 2017 Jun; 17(6):36-42. PubMed ID: 28537834
[TBL] [Abstract][Full Text] [Related]
4. [Placebo and nocebo : How can they be used or avoided?].
Hansen E; Zech N; Meissner K
Internist (Berl); 2017 Oct; 58(10):1102-1110. PubMed ID: 28702702
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of contextual factors as triggers of placebo and nocebo effects in musculoskeletal pain.
Rossettini G; Carlino E; Testa M
BMC Musculoskelet Disord; 2018 Jan; 19(1):27. PubMed ID: 29357856
[TBL] [Abstract][Full Text] [Related]
6. The nocebo effect of informed consent.
Cohen S
Bioethics; 2014 Mar; 28(3):147-54. PubMed ID: 22762392
[TBL] [Abstract][Full Text] [Related]
7. [Exploiting placebo and nocebo effects in patients with chronic pain].
Klinger R
Dtsch Med Wochenschr; 2015 Oct; 140(21):1630-2. PubMed ID: 26488104
[TBL] [Abstract][Full Text] [Related]
8. [Partial disclosure of information in the presence of presumable nocebo effects: an ethical analysis].
Aguilera B; Beca JP
Rev Med Chil; 2018 Apr; 146(4):518-522. PubMed ID: 29999128
[TBL] [Abstract][Full Text] [Related]
9. [Nocebo, informed consent and doctor-patient communication].
Hansen E; Zech N; Benson S
Nervenarzt; 2020 Aug; 91(8):691-699. PubMed ID: 32728796
[TBL] [Abstract][Full Text] [Related]
10. The placebo-nocebo response: controversies and challenges from clinical and research perspective.
Jakovljevic M
Eur Neuropsychopharmacol; 2014 Mar; 24(3):333-41. PubMed ID: 24393653
[TBL] [Abstract][Full Text] [Related]
11. Psychobiological Mechanisms of Placebo and Nocebo Effects: Pathways to Improve Treatments and Reduce Side Effects.
Petrie KJ; Rief W
Annu Rev Psychol; 2019 Jan; 70():599-625. PubMed ID: 30110575
[TBL] [Abstract][Full Text] [Related]
12. Nocebo phenomena in medicine: their relevance in everyday clinical practice.
Häuser W; Hansen E; Enck P
Dtsch Arztebl Int; 2012 Jun; 109(26):459-65. PubMed ID: 22833756
[TBL] [Abstract][Full Text] [Related]
13. Bad is more powerful than good: the nocebo response in medical consultations.
Greville-Harris M; Dieppe P
Am J Med; 2015 Feb; 128(2):126-9. PubMed ID: 25232716
[TBL] [Abstract][Full Text] [Related]
14. Optimizing placebo and minimizing nocebo effects through communication: e-learning and virtual reality training development.
Westendorp J; van Vliet LM; Meeuwis SH; Olde Hartman TC; Sanders ARJ; Jutten E; Dirven M; Peerdeman KJ; Evers AWM
BMC Med Educ; 2024 Jul; 24(1):707. PubMed ID: 38951784
[TBL] [Abstract][Full Text] [Related]
15. Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus.
Evers AWM; Colloca L; Blease C; Annoni M; Atlas LY; Benedetti F; Bingel U; Büchel C; Carvalho C; Colagiuri B; Crum AJ; Enck P; Gaab J; Geers AL; Howick J; Jensen KB; Kirsch I; Meissner K; Napadow V; Peerdeman KJ; Raz A; Rief W; Vase L; Wager TD; Wampold BE; Weimer K; Wiech K; Kaptchuk TJ; Klinger R; Kelley JM
Psychother Psychosom; 2018; 87(4):204-210. PubMed ID: 29895014
[TBL] [Abstract][Full Text] [Related]
16. Preventing adverse events of chemotherapy by educating patients about the nocebo effect (RENNO study) - study protocol of a randomized controlled trial with gastrointestinal cancer patients.
Quidde J; Pan Y; Salm M; Hendi A; Nilsson S; Oechsle K; Stein A; Nestoriuc Y
BMC Cancer; 2018 Sep; 18(1):916. PubMed ID: 30249191
[TBL] [Abstract][Full Text] [Related]
17. [Placebo and nocebo effects on itch : Methodological and clinical implications].
Tekampe J; Peerdeman KJ; Bartels DJP; van Laarhoven AIM; Evers AWM
Hautarzt; 2018 Aug; 69(8):626-630. PubMed ID: 29947820
[TBL] [Abstract][Full Text] [Related]
18. The Placebo and Nocebo Phenomena: Their Clinical Management and Impact on Treatment Outcomes.
Chavarria V; Vian J; Pereira C; Data-Franco J; Fernandes BS; Berk M; Dodd S
Clin Ther; 2017 Mar; 39(3):477-486. PubMed ID: 28237673
[TBL] [Abstract][Full Text] [Related]
19. Using the placebo effect: how expectations and learned immune function can optimize dermatological treatments.
Evers AW
Exp Dermatol; 2017 Jan; 26(1):18-21. PubMed ID: 27489170
[TBL] [Abstract][Full Text] [Related]
20. Neuro-Bio-Behavioral Mechanisms of Placebo and Nocebo Responses: Implications for Clinical Trials and Clinical Practice.
Schedlowski M; Enck P; Rief W; Bingel U
Pharmacol Rev; 2015 Jul; 67(3):697-730. PubMed ID: 26126649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
